Diovan is now the first angiotensin receptor blocker APPROVED for heart failure

September 2002

Diovan is now the first angiotensin receptor blocker APPROVED for heart failure...for patients who can't take an ACE inhibitor.

Diovan (valsartan) reduces mortality by 33% in patients not getting an ACE inhibitor. It also improves ejection fraction...reduces symptoms...and decreases hospitalizations.

Even though Diovan is the only angiotensin receptor blocker approved, other ARBs probably help.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote